UNILENS VISION INC
Healthcare · Ophthalmic Goods · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|
| Revenue | $8.4M | $8.1M | $8.7M | $8.8M | $9.2M |
| Operating income | $1.6M | $1.4M | $2.0M | $2.5M | −$2.7M |
| Net income | $956,312 | $832,626 | $1.1M | $1.5M | $1.5M |
| Total assets | $3.9M | $4.1M | $3.8M | $4.4M | — |
| Total liabilities | $6.9M | $4.6M | $4.7M | $6.0M | — |
| Equity | −$3.0M | −$482,362 | −$888,503 | −$1.6M | −$2.4M |
| EPS (diluted) | $0.50 | $0.35 | $0.48 | $0.63 | $0.43 |
| Shares out. | 1.8M | 2.4M | 2.4M | 2.4M | 3.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- 19.1%
- Net margin
- 11.4%
- Return on equity
- −31.6%
- Return on assets
- 24.8%
- Return on capital (ROCE)
- 90.1%
- Liabilities / assets
- 178.5%
- Debt / equity
- —
- Book value / share
- $-1.73
- Revenue growth (YoY)
- 3.4%
- Net income growth (YoY)
- 14.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- -14.28distress
- Accruals / assets
- −7.0%clean
- Beneish M-Score
- -2.96normal
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 4 good- Negative shareholder equity
- Altman Z″ in the distress zone
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Other material eventJul 14, 2015
- Other material eventMay 15, 2015
- Other material eventFeb 13, 2015
- Shareholder voteDec 17, 2014
- Other material eventNov 14, 2014
- Other material eventSep 29, 2014
- Other material eventMay 15, 2014
- Other material eventFeb 14, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4PRIMARY DOCUMENTSep 17, 2015
- 4PRIMARY DOCUMENTSep 17, 2015
- 4PRIMARY DOCUMENTSep 17, 2015
- 4PRIMARY DOCUMENTSep 17, 2015
- 4PRIMARY DOCUMENTSep 17, 2015
- 15-12GSep 2, 2015
- DEFM14AAug 5, 2015
- 4PRIMARY DOCUMENTJul 24, 2015
- PREM14AJul 17, 2015
- PRE 14AJul 17, 2015
- DEFA14AJul 17, 2015
- SC 13D/AFORM SC 13D/AJul 15, 2015
- 8-KFORM 8-KJul 14, 2015
- 8-KFORM 8-KMay 15, 2015
- 10-QFORM 10-QMay 15, 2015